Literature DB >> 18336473

Human plasma accelerates immortalization of B lymphocytes by Epstein-Barr virus.

E Manor1.   

Abstract

OBJECTIVE: Serum and plasma contain species-specific factors that modulate cell population growth and function, and that are required for proliferation of most cell cultures. Foetal calf serum (FCS) is the most common source of these growth factors. We studied the effect of human plasma (HP) on the immortalization process of B lymphocytes by Epstein-Barr virus (EBV) was studied.
MATERIALS AND METHODS: The effect of HP as compared to FCS was done through assessment of cell proliferation.
RESULTS: It was found that HP (autologous and non-autologous plasma) is more effective than FCS in generating lymphoblastoid cell lines, regardless of EBV status of the donors: 65% of HP-supplemented cultures developed into lymphoblastoid cell lines by 7-14 culture days, as compared to 16% of cultures with FCS. In addition, 6% of HP-supplemented cultures did not achieve becoming lymphoblastoid cell lines by day 35 in comparison to 94% of cultures with FCS. The higher proliferative effect of HP was not altered by heat inactivation or filtration. HP maintained its proliferative activity at 4 degrees C over 8 months, thus indicating that HP contains a stable growth factor(s), which accelerates B-lymphocyte immortalization.
CONCLUSION: The results support other studies that recommend the use of autologous plasma for tissue culture, mainly in the case of autologous transplantation. Furthermore, the use of HP allows preparation of lymphoblastoid cell lines from a small amount of peripheral blood in a shorter period of time and with a higher rate of success.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336473      PMCID: PMC6495120          DOI: 10.1111/j.1365-2184.2008.00513.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  30 in total

1.  Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins.

Authors:  O Gires; F Kohlhuber; E Kilger; M Baumann; A Kieser; C Kaiser; R Zeidler; B Scheffer; M Ueffing; W Hammerschmidt
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

2.  Involvement of platelets in stimulating osteogenic activity.

Authors:  M Slater; J Patava; K Kingham; R S Mason
Journal:  J Orthop Res       Date:  1995-09       Impact factor: 3.494

3.  Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

4.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.

Authors:  H Wakasugi; L Rimsky; Y Mahe; A M Kamel; D Fradelizi; T Tursz; J Bertoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Effects of autologous serum on osteoblastic differentiation in human bone marrow cells.

Authors:  Noriyuki Yamamoto; Masatsugu Isobe; Akihide Negishi; Hidemi Yoshimasu; Hitoyata Shimokawa; Keiichi Ohya; Teruo Amagasa; Shohei Kasugai
Journal:  J Med Dent Sci       Date:  2003-03

6.  Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media.

Authors:  M R Koller; R J Maher; I Manchel; M Oxender; A K Smith
Journal:  J Hematother       Date:  1998-10

7.  Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue.

Authors:  Ryang Hwa Lee; ByungChul Kim; IkSoo Choi; Hanna Kim; Hee Sun Choi; KeunTak Suh; Yong Chan Bae; Jin Sup Jung
Journal:  Cell Physiol Biochem       Date:  2004

8.  All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

Authors:  R K Moorthy; D A Thorley-Lawson
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728

10.  Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.

Authors:  G Tosato; T L Gerrard; N G Goldman; S E Pike
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

View more
  3 in total

1.  Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay.

Authors:  Vahid Younesi; Forough Golsaz Shirazi; Ali Memarian; Amir Amanzadeh; Mahmood Jeddi-Tehrani; Fazel Shokri
Journal:  Cytotechnology       Date:  2013-02-13       Impact factor: 2.058

2.  Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome.

Authors:  Hazir Rahman; Muhammad Qasim; Frank C Schultze; Michael Oellerich; Abdul R Asif
Journal:  Proteome Sci       Date:  2011-11-15       Impact factor: 2.480

Review 3.  EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis.

Authors:  Tingting Yang; Chanping You; Shuhui Meng; Zhengquan Lai; Weipeng Ai; Jun Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.